Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by Cutibacterium acnes (previously known as Propionibacterium acnes), and subsequent inflammation.
Pathogen and Inflammatory Mechanism
A central microbial contributor to this process is C. acnes, whose biological activity contributes to initiating and sustaining the inflammatory response. C. acnes is a Gram-positive, non-spore-forming, anaerobic rod that resides deep within sebaceous follicles. It contributes to acne pathogenesis by producing factors that promote leukocyte recruitment to the follicle. Once there, leukocytes phagocytize the bacteria and release inflammatory mediators, which contribute to follicular rupture and surrounding tissue inflammation. This response is further mediated by innate immune mechanisms, including activation of Toll-like receptors (TLRs) and the release of pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-8. The resultant immune response and accumulation of dead leukocytes contribute to the formation of pustules and the characteristic pus seen in acne lesions.
Clinical Progression and Types
Acne lesions begin with comedones, which result from blocked sebaceous follicles. Blackheads (open comedones) and whiteheads (closed comedones) form due to oxidation or retention of sebum and keratin. Inflammatory lesions can progress to papules and pustules, and in more severe forms like cystic acne, deep nodules and ruptured cysts may result in permanent scarring.
Treatment and Prevention
Mild acne often resolves without intervention, but persistent or severe cases may require treatment. Topical therapies such as benzoyl peroxide, which has keratolytic and antibacterial properties, and retinoids that normalize follicular keratinization are common. Antibiotics like erythromycin or doxycycline are used to target C. acnes, though resistance is a concern. In severe cases, systemic agents like isotretinoin (Accutane) are effective but carry significant teratogenic risks. Emerging non-chemical therapies, such as narrow-band ultraviolet light treatment, have shown promising results in reducing lesion counts, though their long-term efficacy and safety remain under investigation. Despite popular misconceptions, diet and hygiene have minimal impact on acne pathogenesis; the condition originates from within the follicle and is not significantly influenced by surface skin cleansing.
Acne vulgaris is a skin condition characterized by inflammation of hair follicles. Overgrowth of Cutibacterium acnes, along with other factors, contributes to this inflammation.
C. acnes is a Gram-positive, rod-shaped bacterium that thrives in the lipid-rich environment of sebaceous glands.
During adolescence, increased androgen activity stimulates excessive sebum production.
In some individuals, hyperproliferation of keratinocytes, along with trapped sebum in the hair follicle, forms a plug called a microcomedone.
Inside this blocked follicle, C. acnes multiplies and secretes enzymes such as lipases, proteases, and hyaluronidases.
These enzymes break down sebum and extracellular matrix components. This process irritates the surrounding tissue and triggers the release of immune signaling molecules, causing inflammation.
This inflammation may lead to the formation of red papules or pus-filled pustules near the skin surface.
If the follicular wall ruptures under pressure, the contents spread into the dermis. This spread may cause deeper inflammation and the formation of nodules or cysts.
繁體中文
